Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
207 Leser
Artikel bewerten:
(0)

Eversana: EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization

CHICAGO and KANSAS CITY, Mo., Dec. 21, 2021 /PRNewswire/ -- EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, today announced it has completed its acquisition of Intouch Group, a full-service global agency network serving the pharmaceutical industry. The acquisition immediately propels EVERSANA's position as a $1 billion commercial services leader with more than 40 locations and 5,500 employees worldwide, poised to solve any global pricing, access, reimbursement, promotion, adherence, or product delivery challenge.

EVERSANA logo (PRNewsfoto/EVERSANA)

"Today marks a milestone day for not only our employees and clients, but for an industry desperately in need of a better way to bring innovations to market, create long-term value, and improve patient lives," said Jim Lang, CEO of EVERSANA. "With the added power of Intouch and millions more invested in data, analytics and digital transformation, we are reinventing commercial approaches for the benefit of our clients and their patients."

Under terms of the agreement announced in October 2021, Intouch's industry-leading creative and media services, enterprise solutions and data analytics will join EVERSANA's fully integrated commercialization services platform. Agencies from both firms will integrate, as EVERSANA ENGAGE joins forces with the Intouch agency network. Faruk Capan, CEO of Intouch Group, now reports to Jim Lang.

"This is so much more than an integration. This is our opportunity to improve every sector of product commercialization," said Capan. "Over the last 20 years we transformed pharmaceutical promotion and digital engagement. Imagine what the next 20 years will bring as we set our sights even higher, unafraid to transform health care as we know it."

Financial details will not be disclosed. Houlihan Lokey served as the exclusive financial advisor to Intouch Group.

EVERSANA
Sarah Zwicky
Tel +1 (414) 434-4691

Intouch Group
Wendy Blackburn
Tel +1 (913) 530-5207

About EVERSANA
EVERSANA is the leading provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.

About Intouch Group
Intouch Group is a privately held full-service agency network, providing creative and media services, enterprise solutions and data analytics globally through ten affiliates in eight offices, including Intouch Solutions, Intouch Proto, Intouch Seven, Intouch Oxygen, Intouch International, Intouch Media, Intouch B2D, Intouch Analytics, Intouch Market Access, and Intouch MedComm. Collectively, Intouch Group employs more than 1,400 people. With a dedication to the life sciences, Intouch Group operates with the belief that there is no challenge too big to cure. Contact Intouch Group at info@intouchg.com or visit them on the web at intouchg.com.

EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, and Intouch Group, a full-service global agency network serving the pharmaceutical industry, today announced that they signed an agreement to incorporate Intouch's industry-leading creative and media services, enterprise solutions and data analytics into EVERSANA's fully integrated commercialization services platform. (PRNewsfoto/Eversana)

Logo - https://mma.prnewswire.com/media/826977/Eversana_Logo.jpg
Logo - https://mma.prnewswire.com/media/1665632/Intouch_Group_Logo.jpg

© 2021 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.